{"ok":true,"entity":{"id":"waters-corporation","name":"Waters Corporation","entityType":"company","officialName":"Waters Corporation","canonicalName":"Waters Corporation","displayName":"Waters Corporation","category":"分析機器・ライフサイエンス・診断企業","shortDescription":"分析機器、分離技術、ソフトウェアを提供する米国の企業（NYSE: WAT、発表文の発信地はマサチューセッツ州ミルフォード）。2026年2月9日にBDのBiosciences & Diagnostic Solutions事業との統合を完了し、Waters株主が60.8%、BD株主が39.2%（希薄化後）を保有する体制になった。社名は一般名詞「Waters」ではなくWaters Corporationとして扱う。","primaryCluster":"life-science-tools","parentEntity":null,"verificationStatus":"draft","website":"https://www.waters.com","updatedAt":"2026-10-20T07:08:03.177Z","secondaryClusters":[],"alias":["Waters Corp","ウォーターズ"],"searchKeywords":["Waters Corporation","ウォーターズ","Waters","液体クロマトグラフィー","質量分析","BD Biosciences","Reverse Morris Trust","分析機器","ミルフォード"]},"referenceIndex":["P-01-001","P-02-001","P-04-001","P-05-001","P-06-001"]}